BRAF and neoplasm: By contrast, the number of SNPs with a high/moderate (Figure 1C) or only a moderate (Figure S1C) impact on a protein structure/function was significantly higher in the BOT without the BRAF V600E mutation compared to all the remaining tumor groups.